Thompson Siegel & Walmsley’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $7.03M | Buy |
121,984
+66,080
| +118% | +$3.79M | 0.13% | 185 |
|
|
2026
Q1 | $3.39M | Buy |
55,904
+43,750
| +360% | +$2.55M | 0.06% | 258 |
|
|
2025
Q4 | $656K | Sell |
12,154
-200
| -2% | -$9.62K | 0.01% | 334 |
|
|
2025
Q3 | $557K | Hold |
12,354
| – | – | 0.01% | 350 |
|
|
2025
Q2 | $572K | Hold |
12,354
| – | – | 0.01% | 335 |
|
|
2025
Q1 | $753K | Sell |
12,354
-100
| -0.8% | -$5.83K | 0.01% | 304 |
|
|
2024
Q4 | $704K | Sell |
12,454
-146,200
| -92% | -$8.17M | 0.01% | 301 |
|
|
2024
Q3 | $8.21M | Hold |
158,654
| – | – | 0.12% | 153 |
|
|
2024
Q2 | $6.59M | Buy |
158,654
+200
| +0.1% | +$8.95K | 0.11% | 165 |
|
|
2024
Q1 | $8.59M | Hold |
158,454
| – | – | 0.13% | 147 |
|
|
2023
Q4 | $8.13M | Hold |
158,454
| – | – | 0.13% | 144 |
|
|
2023
Q3 | $9.2M | Hold |
158,454
| – | – | 0.15% | 135 |
|
|
2023
Q2 | $10.1M | Buy |
158,454
+15,000
| +10% | +$1.01M | 0.16% | 135 |
|
|
2023
Q1 | $9.94M | Buy |
143,454
+21,550
| +18% | +$1.52M | 0.16% | 133 |
|
|
2022
Q4 | $8.77M | Sell |
121,904
-28,000
| -19% | -$2.11M | 0.14% | 150 |
|
|
2022
Q3 | $10.7M | Sell |
149,904
-52,250
| -26% | -$3.79M | 0.18% | 126 |
|
|
2022
Q2 | $15.6M | Sell |
202,154
-837
| -0.4% | -$63.7K | 0.25% | 105 |
|
|
2022
Q1 | $14.8M | Buy |
202,991
+45,112
| +29% | +$3.03M | 0.21% | 116 |
|
|
2021
Q4 | $9.84M | Buy |
157,879
+38,750
| +33% | +$2.27M | 0.14% | 148 |
|
|
2021
Q3 | $7.05M | Buy |
119,129
+9,600
| +9% | +$632K | 0.1% | 172 |
|
|
2021
Q2 | $7.32M | Hold |
109,529
| – | – | 0.1% | 166 |
|
|
2021
Q1 | $6.92M | Buy |
109,529
+2,829
| +3% | +$176K | 0.1% | 157 |
|
|
2020
Q4 | $6.62M | Sell |
106,700
-1,238
| -1% | -$76.1K | 0.11% | 157 |
|
|
2020
Q3 | $6.51M | Sell |
107,938
-1,107
| -1% | -$66.6K | 0.13% | 145 |
|
|
2020
Q2 | $6.41M | Sell |
109,045
-3,332
| -3% | -$199K | 0.13% | 138 |
|
|
2020
Q1 | $6.26M | Buy |
112,377
+36,708
| +49% | +$2.24M | 0.15% | 127 |
|
|
2019
Q4 | $4.86M | Buy |
75,669
+58,831
| +349% | +$3.37M | 0.07% | 167 |
|
|
2019
Q3 | $854K | Sell |
16,838
-370
| -2% | -$17.4K | 0.01% | 271 |
|
|
2019
Q2 | $780K | Buy |
17,208
+1,440
| +9% | +$67.1K | 0.01% | 286 |
|
|
2019
Q1 | $752K | Hold |
15,768
| – | – | 0.01% | 296 |
|
|
2018
Q4 | $820K | Sell |
15,768
-225
| -1% | -$12.1K | 0.01% | 278 |
|
|
2018
Q3 | $993K | Hold |
15,993
| – | – | 0.01% | 302 |
|
|
2018
Q2 | $885K | Sell |
15,993
-152
| -0.9% | -$8.21K | 0.01% | 308 |
|
|
2018
Q1 | $1.02M | Hold |
16,145
| – | – | 0.01% | 298 |
|
|
2017
Q4 | $989K | Buy |
16,145
+400
| +3% | +$25K | 0.01% | 303 |
|
|
2017
Q3 | $1M | Buy |
15,745
+522
| +3% | +$30.5K | 0.01% | 301 |
|
|
2017
Q2 | $848K | Sell |
15,223
-531
| -3% | -$28.9K | 0.01% | 317 |
|
|
2017
Q1 | $857K | Hold |
15,754
| – | – | 0.01% | 362 |
|
|
2016
Q4 | $921K | Sell |
15,754
-382
| -2% | -$20.9K | 0.01% | 309 |
|
|
2016
Q3 | $870K | Sell |
16,136
-115
| -0.7% | -$7.39K | 0.01% | 302 |
|
|
2016
Q2 | $1.2M | Buy |
16,251
+396
| +2% | +$28K | 0.02% | 270 |
|
|
2016
Q1 | $1.01M | Buy |
15,855
+82
| +0.5% | +$5.17K | 0.02% | 277 |
|
|
2015
Q4 | $1.08M | Hold |
15,773
| – | – | 0.02% | 268 |
|
|
2015
Q3 | $934K | Hold |
15,773
| – | – | 0.02% | 289 |
|
|
2015
Q2 | $1.05M | Sell |
15,773
-6,650
| -30% | -$438K | 0.02% | 283 |
|
|
2015
Q1 | $1.45M | Hold |
22,423
| – | – | 0.03% | 257 |
|
|
2014
Q4 | $1.32M | Hold |
22,423
| – | – | 0.03% | 265 |
|
|
2014
Q3 | $1.15M | Sell |
22,423
-1,075
| -5% | -$53.7K | 0.02% | 265 |
|
|
2014
Q2 | $1.14M | Buy |
23,498
+300
| +1% | +$14.8K | 0.02% | 272 |
|
|
2014
Q1 | $1.21M | Hold |
23,198
| – | – | 0.03% | 266 |
|
|
2013
Q4 | $1.23M | Sell |
23,198
-2,600
| -10% | -$132K | 0.03% | 274 |
|
|
2013
Q3 | $1.19M | Sell |
25,798
-23,200
| -47% | -$1.02M | 0.03% | 273 |
|
|
2013
Q2 | $2.19M | Buy |
+48,998
| New | +$2.13M | 0.05% | 270 |
|
Other funds holding BMY
Thompson Siegel & Walmsley's BMY Position: Q2 2026 in Review
Thompson Siegel & Walmsley increased its Bristol-Myers Squibb (BMY) stake by 118% in Q2 2026, buying an estimated $3.79M and bringing the position to 121,984 shares worth $7.03M. The position accounts for 0.13% of the portfolio, ranked #185.
Thompson Siegel & Walmsley first reported a position in BMY in Q2 2013 and has held it in 53 quarters since. The position peaked at $15.6M in Q2 2022. 2,511 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Thompson Siegel & Walmsley held 121,984 shares of Bristol-Myers Squibb worth $7.03M as of Q2 2026.
- Thompson Siegel & Walmsley bought 66,080 Bristol-Myers Squibb shares in Q2 2026, an estimated $3.79M.
- Bristol-Myers Squibb made up 0.13% of Thompson Siegel & Walmsley's portfolio in Q2 2026, its #185 holding.
- Thompson Siegel & Walmsley first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 53 quarters since.
- Thompson Siegel & Walmsley's Bristol-Myers Squibb position peaked at $15.6M in Q2 2022.
- 2,511 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Thompson Siegel & Walmsley's 13F filing for Q2 2026, filed 11 Aug 2026.